Click for best price
Metastatic Cancer Treatment Market Size, Share 2022
Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast cancer. Although cancer has spread to other parts of the body, but it is treated as breast cancer only. Usually, metastatic breast cancer occurs months or years after completion of treatment for early or locally advanced stages of breast cancer. Metastatic breast cancer cannot be cured. As it has spread to other organs, so it becomes impossible to get rid of all types of cancer. But the treatment of metastatic breast cancer can extend patient?s life with increasing quality of life. Treatment of metastatic breast cancer is influenced by factors such as symptoms, past treatments, cancer cell characteristics and organs affected.
This report contains market size and forecasts of Metastatic Cancer Treatment in Global, including the following market information:
Global Metastatic Cancer Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Metastatic Cancer Treatment market was valued at 51690 million in 2021 and is projected to reach US$ 68940 million by 2028, at a CAGR of 4.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Chemotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Metastatic Cancer Treatment include Roche, Novartis, Merck, Eli Lilly, Johnson & Johnson, Pfizer, AstraZeneca, GlaxoSmithKline and Sun Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Metastatic Cancer Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Metastatic Cancer Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Metastatic Cancer Treatment Market Segment Percentages, by Type, 2021 (%)
Chemotherapy
Radiation Therapy
Biologic Targeted Therapy
Hormone Therapy
Global Metastatic Cancer Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Metastatic Cancer Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Other
Global Metastatic Cancer Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Metastatic Cancer Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Metastatic Cancer Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Metastatic Cancer Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Novartis
Merck
Eli Lilly
Johnson & Johnson
Pfizer
AstraZeneca
GlaxoSmithKline
Sun Pharmaceutical
Bayer
Gilead Sciences
| Report Attributes |
Report Details |
| Report Title |
Metastatic Cancer Treatment Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Metastatic Cancer Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Metastatic Cancer Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Metastatic Cancer Treatment Overall Market Size
2.1 Global Metastatic Cancer Treatment Market Size: 2021 VS 2028
2.2 Global Metastatic Cancer Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Metastatic Cancer Treatment Players in Global Market
3.2 Top Global Metastatic Cancer Treatment Companies Ranked by Revenue
3.3 Global Metastatic Cancer Treatment Revenue by Companies
3.4 Top 3 and Top 5 Metastatic Cancer Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Metastatic Cancer Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Metastatic Cancer Treatment Players in Global Market
3.6.1 List of Global Tier 1 Metastatic Cancer Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Metastatic Cancer Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Metastatic Cancer Treatment Market Size Markets, 2021 & 2028
4.1.2 Chemotherapy
4.1.3 Radiation Therapy
4.1.4 Biologic Targeted Therapy
4.1.5 Hormone Therapy
4.2 By Type - Global Metastatic Cancer Treatment Revenue & Forecasts
4.2.1 By Type - Global Metastatic Cancer Treatment Revenue, 2017-2022
4.2.2 By Type - Global Metastatic Cancer Treatment Revenue, 2023-2028
4.2.3 By Type - Global Metastatic Cancer Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Metastatic Cancer Treatment Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Other
5.2 By Application - Global Metastatic Cancer Treatment Revenue & Forecasts
5.2.1 By Application - Global Metastatic Cancer Treatment Revenue, 2017-2022
5.2.2 By Application - Global Metastatic Cancer Treatment Revenue, 2023-2028
5.2.3 By Application - Global Metastatic Cancer Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Metastatic Cancer Treatment Market Size, 2021 & 2028
6.2 By Region - Global Metastatic Cancer Treatment Revenue & Forecasts
6.2.1 By Region - Global Metastatic Cancer Treatment Revenue, 2017-2022
6.2.2 By Region - Global Metastatic Cancer Treatment Revenue, 2023-2028
6.2.3 By Region - Global Metastatic Cancer Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Metastatic Cancer Treatment Revenue, 2017-2028
6.3.2 US Metastatic Cancer Treatment Market Size, 2017-2028
6.3.3 Canada Metastatic Cancer Treatment Market Size, 2017-2028
6.3.4 Mexico Metastatic Cancer Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Metastatic Cancer Treatment Revenue, 2017-2028
6.4.2 Germany Metastatic Cancer Treatment Market Size, 2017-2028
6.4.3 France Metastatic Cancer Treatment Market Size, 2017-2028
6.4.4 U.K. Metastatic Cancer Treatment Market Size, 2017-2028
6.4.5 Italy Metastatic Cancer Treatment Market Size, 2017-2028
6.4.6 Russia Metastatic Cancer Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Metastatic Cancer Treatment Market Size, 2017-2028
6.4.8 Benelux Metastatic Cancer Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Metastatic Cancer Treatment Revenue, 2017-2028
6.5.2 China Metastatic Cancer Treatment Market Size, 2017-2028
6.5.3 Japan Metastatic Cancer Treatment Market Size, 2017-2028
6.5.4 South Korea Metastatic Cancer Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Metastatic Cancer Treatment Market Size, 2017-2028
6.5.6 India Metastatic Cancer Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Metastatic Cancer Treatment Revenue, 2017-2028
6.6.2 Brazil Metastatic Cancer Treatment Market Size, 2017-2028
6.6.3 Argentina Metastatic Cancer Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Metastatic Cancer Treatment Revenue, 2017-2028
6.7.2 Turkey Metastatic Cancer Treatment Market Size, 2017-2028
6.7.3 Israel Metastatic Cancer Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Metastatic Cancer Treatment Market Size, 2017-2028
6.7.5 UAE Metastatic Cancer Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Metastatic Cancer Treatment Major Product Offerings
7.1.4 Roche Metastatic Cancer Treatment Revenue in Global Market (2017-2022)
7.1.5 Roche Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Metastatic Cancer Treatment Major Product Offerings
7.2.4 Novartis Metastatic Cancer Treatment Revenue in Global Market (2017-2022)
7.2.5 Novartis Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck Metastatic Cancer Treatment Major Product Offerings
7.3.4 Merck Metastatic Cancer Treatment Revenue in Global Market (2017-2022)
7.3.5 Merck Key News
7.4 Eli Lilly
7.4.1 Eli Lilly Corporate Summary
7.4.2 Eli Lilly Business Overview
7.4.3 Eli Lilly Metastatic Cancer Treatment Major Product Offerings
7.4.4 Eli Lilly Metastatic Cancer Treatment Revenue in Global Market (2017-2022)
7.4.5 Eli Lilly Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Metastatic Cancer Treatment Major Product Offerings
7.5.4 Johnson & Johnson Metastatic Cancer Treatment Revenue in Global Market (2017-2022)
7.5.5 Johnson & Johnson Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Metastatic Cancer Treatment Major Product Offerings
7.6.4 Pfizer Metastatic Cancer Treatment Revenue in Global Market (2017-2022)
7.6.5 Pfizer Key News
7.7 AstraZeneca
7.7.1 AstraZeneca Corporate Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Metastatic Cancer Treatment Major Product Offerings
7.7.4 AstraZeneca Metastatic Cancer Treatment Revenue in Global Market (2017-2022)
7.7.5 AstraZeneca Key News
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Corporate Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline Metastatic Cancer Treatment Major Product Offerings
7.8.4 GlaxoSmithKline Metastatic Cancer Treatment Revenue in Global Market (2017-2022)
7.8.5 GlaxoSmithKline Key News
7.9 Sun Pharmaceutical
7.9.1 Sun Pharmaceutical Corporate Summary
7.9.2 Sun Pharmaceutical Business Overview
7.9.3 Sun Pharmaceutical Metastatic Cancer Treatment Major Product Offerings
7.9.4 Sun Pharmaceutical Metastatic Cancer Treatment Revenue in Global Market (2017-2022)
7.9.5 Sun Pharmaceutical Key News
7.10 Bayer
7.10.1 Bayer Corporate Summary
7.10.2 Bayer Business Overview
7.10.3 Bayer Metastatic Cancer Treatment Major Product Offerings
7.10.4 Bayer Metastatic Cancer Treatment Revenue in Global Market (2017-2022)
7.10.5 Bayer Key News
7.11 Gilead Sciences
7.11.1 Gilead Sciences Corporate Summary
7.11.2 Gilead Sciences Business Overview
7.11.3 Gilead Sciences Metastatic Cancer Treatment Major Product Offerings
7.11.4 Gilead Sciences Metastatic Cancer Treatment Revenue in Global Market (2017-2022)
7.11.5 Gilead Sciences Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Metastatic Cancer Treatment Market Opportunities & Trends in Global Market
Table 2. Metastatic Cancer Treatment Market Drivers in Global Market
Table 3. Metastatic Cancer Treatment Market Restraints in Global Market
Table 4. Key Players of Metastatic Cancer Treatment in Global Market
Table 5. Top Metastatic Cancer Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Metastatic Cancer Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Metastatic Cancer Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Metastatic Cancer Treatment Product Type
Table 9. List of Global Tier 1 Metastatic Cancer Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Metastatic Cancer Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Metastatic Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Metastatic Cancer Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Metastatic Cancer Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Metastatic Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Metastatic Cancer Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Metastatic Cancer Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Metastatic Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Metastatic Cancer Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Metastatic Cancer Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Metastatic Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Metastatic Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Metastatic Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Metastatic Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Metastatic Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Metastatic Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Metastatic Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Metastatic Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Metastatic Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Metastatic Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche Metastatic Cancer Treatment Product Offerings
Table 32. Roche Metastatic Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Metastatic Cancer Treatment Product Offerings
Table 35. Novartis Metastatic Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Merck Corporate Summary
Table 37. Merck Metastatic Cancer Treatment Product Offerings
Table 38. Merck Metastatic Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Eli Lilly Corporate Summary
Table 40. Eli Lilly Metastatic Cancer Treatment Product Offerings
Table 41. Eli Lilly Metastatic Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson Metastatic Cancer Treatment Product Offerings
Table 44. Johnson & Johnson Metastatic Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer Corporate Summary
Table 46. Pfizer Metastatic Cancer Treatment Product Offerings
Table 47. Pfizer Metastatic Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 48. AstraZeneca Corporate Summary
Table 49. AstraZeneca Metastatic Cancer Treatment Product Offerings
Table 50. AstraZeneca Metastatic Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 51. GlaxoSmithKline Corporate Summary
Table 52. GlaxoSmithKline Metastatic Cancer Treatment Product Offerings
Table 53. GlaxoSmithKline Metastatic Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Sun Pharmaceutical Corporate Summary
Table 55. Sun Pharmaceutical Metastatic Cancer Treatment Product Offerings
Table 56. Sun Pharmaceutical Metastatic Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Bayer Corporate Summary
Table 58. Bayer Metastatic Cancer Treatment Product Offerings
Table 59. Bayer Metastatic Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Gilead Sciences Corporate Summary
Table 61. Gilead Sciences Metastatic Cancer Treatment Product Offerings
Table 62. Gilead Sciences Metastatic Cancer Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Metastatic Cancer Treatment Segment by Type in 2021
Figure 2. Metastatic Cancer Treatment Segment by Application in 2021
Figure 3. Global Metastatic Cancer Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Metastatic Cancer Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Metastatic Cancer Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Metastatic Cancer Treatment Revenue in 2021
Figure 8. By Type - Global Metastatic Cancer Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Metastatic Cancer Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Metastatic Cancer Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Metastatic Cancer Treatment Revenue Market Share, 2017-2028
Figure 12. US Metastatic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Metastatic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Metastatic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Metastatic Cancer Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Metastatic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Metastatic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Metastatic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Metastatic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Metastatic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Metastatic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Metastatic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Metastatic Cancer Treatment Revenue Market Share, 2017-2028
Figure 24. China Metastatic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Metastatic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Metastatic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Metastatic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Metastatic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Metastatic Cancer Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Metastatic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Metastatic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Metastatic Cancer Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Metastatic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Metastatic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Metastatic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Metastatic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Metastatic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Metastatic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Merck Metastatic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Eli Lilly Metastatic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Johnson & Johnson Metastatic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer Metastatic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AstraZeneca Metastatic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. GlaxoSmithKline Metastatic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Sun Pharmaceutical Metastatic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Bayer Metastatic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Gilead Sciences Metastatic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
